NeuroVive: NeuroVive Obtains U.S. Orphan Drug Designation for Traumatic Brain Injury
Note: This is an English version of a press release communicated by NeuroVive 2010-12-01 December 6, 2010 - Lund, Sweden. NeuroVive Pharmaceutical AB (NVP) announces that the U.S. FDA Office of Orphan ...